POLARx Cardiac Cryoablation System Study

NCT04250714 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2025-04-04

Study results available
· View outcomes & findings →

Summary

This is a Post Market Clinical Follow-up (PMCF) study designed to establish the continued safety and effectiveness profile of the Boston Scientific Cardiac Cryoablation System after receiving CE mark.

Conditions

Interventions

DEVICE

Boston Scientific Cardiac Cryoablation System

cryoablation of atrial fibrillation consisting in electrical isolation of the pulmonary veins

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-06
Primary Completion
2022-09-26
Completion
2022-09-26

Countries

  • Belgium
  • Croatia
  • France
  • Germany
  • Italy
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04250714 on ClinicalTrials.gov